CVS Health Corporation

Equities

CVS

US1266501006

Healthcare Facilities & Services

Market Closed - Nyse Other stock markets 04:00:02 2024-05-10 pm EDT			5-day change	1st Jan Change
55.82 ^USD	+0.25%		-0.14%	-29.31%

May. 08	Argus Research Adjusts Price Target on CVS Health to $80 From $100	MT
May. 08	Mickey Mouse on Wall Street

CVS Health Corporation Reports Earnings Results for the First Quarter Ended March 31, 2022

May 04, 2022 at 06:35 am EDT

CVS Health Corporation reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was USD 21,631 million compared to USD 18,960 million a year ago. Revenue was USD 76,826 million compared to USD 69,097 million a year ago. Net income was USD 2,312 million compared to USD 2,223 million a year ago. Basic earnings per share from continuing operations was USD 1.76 compared to USD 1.69 a year ago. Diluted earnings per share from continuing operations was USD 1.74 compared to USD 1.68 a year ago.

Latest news about CVS Health Corporation

Argus Research Adjusts Price Target on CVS Health to $80 From $100	May. 08	MT
Mickey Mouse on Wall Street	May. 08
ANALYST RECOMMENDATIONS : Walt Disney, Tractor Supply Company, KKR, Occidental Petroleum...	May. 08
CVS Health Files Prospectus Supplement for Notes Sale	May. 07	MT
FOMO is Back	May. 07
ANALYST RECOMMENDATIONS : Nvidia, The Home Depot, Lowe's, Rollins...	May. 07
Wells Fargo Adjusts CVS Health's Price Target to $60 From $76	May. 07	MT
TD Cowen Downgrades CVS Health to Hold From Buy, Adjusts Price Target to $59 From $99	May. 07	MT
Ameriprise Downgrades CVS Health to Hold From Buy	May. 06	MT
Aetna will cover fertility treatments for LGBTQ people under court settlement	May. 03	RE
ARC Independent Research Adjusts Price Target on CVS Health to $65 From $80	May. 03	MT
Wall Street rises thanks to good and bad economic news	May. 03
North American Morning Briefing : Apple, Amgen -2-	May. 03	DJ
ANALYST RECOMMENDATIONS : Alphabet, Amgen, Starbucks, PayPal, Moderna...	May. 03
HSBC Downgrades CVS Health to Hold From Buy, Adjusts Price Target to $62 From $91	May. 03	MT
Cvs Health Insider Bought Shares Worth $500,294, According to a Recent SEC Filing	May. 02	MT
Deutsche Bank Adjusts Price Target on CVS Health to $64 From $77	May. 02	MT
Raymond James Adjusts Price Target on CVS Health to $65 From $85	May. 02	MT
Wolfe Adjusts Price Target on CVS Health to $70 From $88	May. 02	MT
Morgan Stanley Adjusts Price Target on CVS Health to $65 From $85	May. 02	MT
Jefferies Adjusts Price Target on CVS Health to $72 From $95	May. 02	MT
Barclays Adjusts Price Target on CVS Health to $63 From $78	May. 02	MT
Bernstein Adjusts Price Target on CVS Health to $62 From $93	May. 02	MT
Mizuho Adjusts Price Target on CVS Health to $72 From $86	May. 02	MT
Truist Lowers CVS Health's PT to $66 From $90 After Below-Consensus Q1 Results, Reduced Guidance; Keeps Buy Rating	May. 02	MT

Chart CVS Health Corporation

Duration

Period

More charts

Company Profile

CVS Health Corporation is one of the leading American suppliers of health products and services. Net sales (including intragroup) break down by activity as follows: - medical insurance plan management services (45.6%; Pharmacy Benefit Management): administrative management (reimbursement management, patient claim processing, etc.), drug distribution, decision-making information, sales of medical information management services, etc.; - retail distribution (28.5%): sale of prescription pharmaceutical products, OTC products, beauty and cosmetics products. At the end of 2023, products are marketed primarily via a network of more than 9,000 outlets and via the Internet. In addition, the group offers healthcare services through more than 1,000 clinics (MinuteClinic®); - medical benefits management (25.8%); - other (0.1%).

Sector

Healthcare Facilities & Services

Calendar

2024-05-14 - BofA Securities Health Care Conference

Related indices

S&P 500

More about the company

Income Statement Evolution

More financial data

Ratings for CVS Health Corporation

Trading Rating

Investor Rating

ESG Refinitiv

B-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

55.82 USD

Average target price

71.37 USD

Spread / Average Target

+27.86%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Healthcare Facilities & Services

	1st Jan change	Capi.
CVS HEALTH CORPORATION	-29.31%	70.07B
HCA HEALTHCARE, INC.	+20.68%	85.55B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY	+9.23%	29.06B
LABORATORY CORPORATION OF AMERICA HOLDINGS	-8.63%	17.51B
FRESENIUS SE & CO. KGAA	+2.14%	17.39B
QUEST DIAGNOSTICS INCORPORATED	+0.39%	15.38B
REDE D'OR SÃO LUIZ S.A.	+6.47%	13.4B
NATERA, INC.	+68.09%	12.87B
FRESENIUS MEDICAL CARE AG	+6.43%	12.77B
TENET HEALTHCARE CORPORATION	+68.23%	12.42B

Other Healthcare Facilities & Services